Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,334
datasets available to search
ShareScore release 0.9.0
Dataset results
1,334 results for “Hematology”
Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies
ClinicalTrials.gov study NCT00718757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic H
ClinicalTrials.gov study NCT02342613. IPD Sharing: NO. Countries: 1. Publications: 0.
Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
ClinicalTrials.gov study NCT07346105. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
ClinicalTrials.gov study NCT00003805. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
ClinicalTrials.gov study NCT00104975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of a Training Programme in the Variation of Fitness Parameters, Physiological, Hematological and Biochemical Indicators of Soccer Players During the Preseason Period
ClinicalTrials.gov study NCT07170930. IPD Sharing: YES. Countries: 1. Publications: 0.
Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.
ClinicalTrials.gov study NCT01066468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
ClinicalTrials.gov study NCT06849921. IPD Sharing: NO. Countries: 1. Publications: 0.
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
ClinicalTrials.gov study NCT00317785. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT05589896. IPD Sharing: NO. Countries: 1. Publications: 0.
Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy
ClinicalTrials.gov study NCT05009719. IPD Sharing: NO. Countries: 1. Publications: 0.
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT05536154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
ClinicalTrials.gov study NCT06900114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic Failure
ClinicalTrials.gov study NCT03399149. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
ClinicalTrials.gov study NCT05088356. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
ClinicalTrials.gov study NCT07195916. IPD Sharing: NO. Countries: 5. Publications: 0.
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov study NCT00003960. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
ClinicalTrials.gov study NCT05556928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT06550713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies
ClinicalTrials.gov study NCT02924402. IPD Sharing: NO. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.